Outreach: Preliminary Safety and Efficacy Results from a Phase 2 Study of Lisocabtagene Maraleucel (Liso-Cel) in the Nonuniversity Setting.
Journal of clinical oncology(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of clinical oncology(2021)